Literature DB >> 32042809

Pulmonary lesions associated with sputum culture-positive actinomycetes: report of one case.

Lingwei Wang1, Heng Zhang1, Di Wu1, Mengjie Feng1, Peng Yang1, Xiaoyi Hu1, Pierre Tattevin2, Goohyeon Hong3, Rongchang Chen1, Chen Qiu1.   

Abstract

Pulmonary actinomycosis (PA) is a rare subacute or chronic infectious disease. As simple culture of Actinomyces in BAL, as with sputum, may represent colonization, the diagnosis of PA relies on pathological examination. The preferred treatment is long-term, high-dose penicillin. A 6-12-month-course of antibacterial treatment is the rule in extended PA, although the optimal duration of treatment has not been investigated through randomized trial. In this article, we report a case presented with slowly-progressing pulmonary cavitary lesions. Actinomyces odontolyticus was detected in sputum specimen harvested by tracheoscopy. The clinical diagnosis was PA, which gradually improved with prolonged treatment of penicillin and ornidazole. This is followed by a discussion of diagnosis and treatment, especially in terms of treatment. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Pulmonary actinomycosis (PA); anaerobic bacteria

Year:  2019        PMID: 32042809      PMCID: PMC6990027          DOI: 10.21037/atm.2019.12.38

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  8 in total

1.  Chapter 2-12-1. Anaerobic infections (individual fields): actinomycosis.

Authors: 
Journal:  J Infect Chemother       Date:  2011-07       Impact factor: 2.211

Review 2.  Actinomycosis: a frequently forgotten disease.

Authors:  Lyudmila Boyanova; Rossen Kolarov; Lyudmila Mateva; Rumyana Markovska; Ivan Mitov
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

3.  Differential diagnosis of acute miliary pulmonary tuberculosis from widespread-metastatic cancer for postoperative lung cancer patients: two cases.

Authors:  Wei Zhao; Yuke Tian; Feng Peng; Jianlin Long; Lan Liu; Meijuan Huang; You Lu
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

4.  Executive summary: a guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).

Authors:  Ellen Jo Baron; J Michael Miller; Melvin P Weinstein; Sandra S Richter; Peter H Gilligan; Richard B Thomson; Paul Bourbeau; Karen C Carroll; Sue C Kehl; W Michael Dunne; Barbara Robinson-Dunn; Joseph D Schwartzman; Kimberle C Chapin; James W Snyder; Betty A Forbes; Robin Patel; Jon E Rosenblatt; Bobbi S Pritt
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

5.  Thoracic actinomycosis: CT features with histopathologic correlation.

Authors:  Tae Sung Kim; Joungho Han; Won-Jung Koh; Jae Chol Choi; Myung Jin Chung; Ju Hyun Lee; Sung Shine Shim; Semin Chong
Journal:  AJR Am J Roentgenol       Date:  2006-01       Impact factor: 3.959

Review 6.  Imaging of actinomycosis in various organs: a comprehensive review.

Authors:  Suk Hee Heo; Sang Soo Shin; Jin Woong Kim; Hyo Soon Lim; Hyun Ju Seon; Sook-In Jung; Yong Yeon Jeong; Heoung Keun Kang
Journal:  Radiographics       Date:  2014 Jan-Feb       Impact factor: 5.333

Review 7.  Endobronchial actinomycosis associated with foreign body: four cases and a review of the literature.

Authors:  Stéphane Chouabe; Dominique Perdu; Gaétan Deslée; Dragisa Milosevic; Elisabeth Marque; François Lebargy
Journal:  Chest       Date:  2002-06       Impact factor: 9.410

Review 8.  Actinomycosis: etiology, clinical features, diagnosis, treatment, and management.

Authors:  Florent Valour; Agathe Sénéchal; Céline Dupieux; Judith Karsenty; Sébastien Lustig; Pierre Breton; Arnaud Gleizal; Loïc Boussel; Frédéric Laurent; Evelyne Braun; Christian Chidiac; Florence Ader; Tristan Ferry
Journal:  Infect Drug Resist       Date:  2014-07-05       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.